- $699.28m
- $635.11m
- $146.37m
- 51
- 27
- 84
- 53
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 32.4 | 34.7 | 169 | 142 | 146 |
Cost of Revenue | |||||
Gross Profit | 11.4 | 2.87 | 111 | 10.5 | -21.5 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 31.3 | 40 | 107 | 425 | 230 |
Operating Profit | 1.09 | -5.29 | 62.8 | -283 | -83.2 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.484 | -16.1 | 42.6 | -256 | -104 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2.11 | -16.3 | 22.1 | -239 | -104 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 2.9 | -16.3 | 22.1 | -239 | -104 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2.9 | -16.3 | 22.1 | -239 | -104 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.041 | -0.181 | 0.144 | -0.39 | -0.337 |